Navigation Links
Cedars-Sinai awarded $2.5 million to study potential new drug treatments for Alzheimer's disease

LOS ANGELES (Feb. 20, 2012) A Cedars-Sinai research scientist has been awarded two national grants totaling more than $2.5 million, including a prestigious Research Project Grant from the National Institutes of Health to study potential treatments for Alzheimer's disease.

Terrence Town, PhD, is studying drugs that potentially could disrupt the formation and accumulation of sticky amyloid plaques that build up in the brain and are widely considered a root cause of Alzheimer's disease, a chronic and fatal condition that impairs memory and cognition. In the disease's final stages, patients require round-the-clock care.

Amyloid is an abnormal protein usually produced in the bone marrow that can be deposited in any tissue or organ. An unhealthy buildup of the protein is believed to lead to diseases such as Alzheimer's.

"Alzheimer's has the potential to bankrupt this country,'' said Town, PhD, the studies' principal investigator and research scientist in the Cedars-Sinai Regenerative Medicine Institute and the Departments of Biomedical Sciences and Neurosurgery. "It is the public health crisis of our time and the big question is: what are we going to do about it? Our approach is to target the body's immune system to clean up amyloid plaques and thereby allow brain regeneration."

The NIH grant totals more than $2 million over five years and is earmarked for the study of macrophages, common cells that circulate in the blood and are capable of clearing damaging substances, such as plaques.

"Our goal is to identify drugs that give the signal to macrophages to enter the brain and eat away at the amyloid plaque buildup," said Town, the Ben Winters Chair in Regenerative Medicine. "These macrophages have a central mission in life: to eat noxious substances. But because the brain is somewhat shielded from the immune system, peripheral macrophages are given the message not to go into the brain and eat the amyloid plaques. So, if we could identify what's blocking this beneficial response in these cells, the hope is that a drug would enable the macrophages to leave the blood, go into the brain and remove the plaques."

The second grant, for $550,000, was awarded by the American Federation of Aging Research and will enable Town and his team of researchers to study new ways to reduce brain inflammation.

"Understanding this important area of neuroimmunology will likely lead to new therapeutic targets for Alzheimer's,'' Town said.

The author of more than 90 scientific publications, Town is a well-known neuroimmunologist whose research focuses on understanding and treating neurologic disorders including Alzheimer's, viral encephalitis and stroke.

According to the Alzheimer's Association, more than 5.4 million Americans have the disease, and its incidence is on the rise. Alzheimer's destroys brain cells, causing memory, thinking and behavioral problems severe enough to affect work, family and social relationships. It eventually affects the basics of daily living, is incurable and, ultimately, is fatal. Alzheimer's is the sixth-leading cause of death in the United States and the fifth-leading cause for people 65 and older, association statistics show.


Contact: Sally Stewart
Cedars-Sinai Medical Center

Related medicine news :

1. Moderate red wine drinking may help cut womens breast cancer risk, Cedars-Sinai study shows
2. Cedars-Sinai study: How does a good protein hurt brain cells after clot-induced stroke?
3. TGen and Virginia G. Piper Cancer Center form drug development collaboration with Cedars-Sinai
4. Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit
5. Cedars-Sinai movement disorders expert on international task force for dystonia treatment
6. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
7. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
8. Cedars-Sinai to hold first annual conference on stem cell therapies for neurological disorders
9. Cedars-Sinais mobile medical clinics receive grant from George Hoag Family Foundation
10. Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies
11. Cedars-Sinai Medical Genetics Institute director honored with lifetime achievement award
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... 2016  Guerbet announced today that it has been ... Award . One of 12 suppliers to ... its support of Premier members through exceptional local customer ... commitment to lower costs. ... our outstanding customer service from Premier," says Massimo ...
Breaking Medicine Technology: